IL6 and cancer: Simultaneously, IL-6/STAT3 signaling in malignant EMT leads to the acquisition of cancer stemness in cancer cells; self-renewal and population expansion of CSCs need STAT3 in collaboration with stem-cell-associated transcription factors [23].